866-997-4948(US-Canada Toll Free)

EMEA (Europe, Middle East and Africa) Type 1 Diabetes Drugs Market Report 2017

Published By :

QYResearch

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 124 Pages

In this report, the EMEA Type 1 Diabetes Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Type 1 Diabetes Drugs for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Type 1 Diabetes Drugs market competition by top manufacturers/players, with Type 1 Diabetes Drugs sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Novo Nordisk(US)
Sanofi(DE)
Eli Lilly(UK)
ASTRAZENECA(JP)
Medtronic(IT)
Insulet(US)
TANDEM(CH)
ATI(US)
Novartis(US)
BOEHRINGER INGELHEIM(US)
Bristol-Myers Squibb(US)
Takada(US)
HUADONG MEDICINE(DE)
Kelun(US)
NCPC(US)
Wanbang(IT)
Hisun(DE)
Yiling(US)
Gan & Lee(US)
Dongbao(IT)
JUMCAN(SK)
Taloph(US)
TIANAN(IT)
Ginwa(ES)
Baiyun Mountain(JP)
KOSAPLUS(KR)
Burkert(DE)

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Peroral Drugs
Injection

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Type 1 Diabetes Drugs for each application, including
Hospital
Clinic

Table of Contents

EMEA (Europe, Middle East and Africa) Type 1 Diabetes Drugs Market Report 2017
1 Type 1 Diabetes Drugs Overview
1.1 Product Overview and Scope of Type 1 Diabetes Drugs
1.2 Classification of Type 1 Diabetes Drugs
1.2.1 EMEA Type 1 Diabetes Drugs Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Type 1 Diabetes Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Peroral Drugs
1.2.4 Injection
1.3 EMEA Type 1 Diabetes Drugs Market by Application/End Users
1.3.1 EMEA Type 1 Diabetes Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Hospital
1.3.3 Clinic
1.4 EMEA Type 1 Diabetes Drugs Market by Region
1.4.1 EMEA Type 1 Diabetes Drugs Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Type 1 Diabetes Drugs (2012-2022)
1.5.1 EMEA Type 1 Diabetes Drugs Sales and Growth Rate (2012-2022)
1.5.2 EMEA Type 1 Diabetes Drugs Revenue and Growth Rate (2012-2022)

2 EMEA Type 1 Diabetes Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Type 1 Diabetes Drugs Market Competition by Players/Manufacturers
2.1.1 EMEA Type 1 Diabetes Drugs Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Type 1 Diabetes Drugs Revenue and Share by Players (2012-2017)
2.1.3 EMEA Type 1 Diabetes Drugs Sale Price by Players (2012-2017)
2.2 EMEA Type 1 Diabetes Drugs (Volume and Value) by Type/Product Category
2.2.1 EMEA Type 1 Diabetes Drugs Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Type 1 Diabetes Drugs Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Type 1 Diabetes Drugs Sale Price by Type (2012-2017)
2.3 EMEA Type 1 Diabetes Drugs (Volume) by Application
2.4 EMEA Type 1 Diabetes Drugs (Volume and Value) by Region
2.4.1 EMEA Type 1 Diabetes Drugs Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Type 1 Diabetes Drugs Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Type 1 Diabetes Drugs Sales Price by Region (2012-2017)

3 Europe Type 1 Diabetes Drugs (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Type 1 Diabetes Drugs Sales and Value (2012-2017)
3.1.1 Europe Type 1 Diabetes Drugs Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Type 1 Diabetes Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Type 1 Diabetes Drugs Sales and Market Share by Type
3.3 Europe Type 1 Diabetes Drugs Sales and Market Share by Application
3.4 Europe Type 1 Diabetes Drugs Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Type 1 Diabetes Drugs Sales Volume by Countries (2012-2017)
3.4.2 Europe Type 1 Diabetes Drugs Revenue by Countries (2012-2017)
3.4.3 Germany Type 1 Diabetes Drugs Sales and Growth Rate (2012-2017)
3.4.4 France Type 1 Diabetes Drugs Sales and Growth Rate (2012-2017)
3.4.5 UK Type 1 Diabetes Drugs Sales and Growth Rate (2012-2017)
3.4.6 Russia Type 1 Diabetes Drugs Sales and Growth Rate (2012-2017)
3.4.7 Italy Type 1 Diabetes Drugs Sales and Growth Rate (2012-2017)
3.4.8 Benelux Type 1 Diabetes Drugs Sales and Growth Rate (2012-2017)

4 Middle East Type 1 Diabetes Drugs (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Type 1 Diabetes Drugs Sales and Value (2012-2017)
4.1.1 Middle East Type 1 Diabetes Drugs Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Type 1 Diabetes Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Type 1 Diabetes Drugs Sales and Market Share by Type
4.3 Middle East Type 1 Diabetes Drugs Sales and Market Share by Application
4.4 Middle East Type 1 Diabetes Drugs Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Type 1 Diabetes Drugs Sales Volume by Countries (2012-2017)
4.4.2 Middle East Type 1 Diabetes Drugs Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Type 1 Diabetes Drugs Sales and Growth Rate (2012-2017)
4.4.4 Israel Type 1 Diabetes Drugs Sales and Growth Rate (2012-2017)
4.4.5 UAE Type 1 Diabetes Drugs Sales and Growth Rate (2012-2017)
4.4.6 Iran Type 1 Diabetes Drugs Sales and Growth Rate (2012-2017)

5 Africa Type 1 Diabetes Drugs (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Type 1 Diabetes Drugs Sales and Value (2012-2017)
5.1.1 Africa Type 1 Diabetes Drugs Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Type 1 Diabetes Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Type 1 Diabetes Drugs Sales and Market Share by Type
5.3 Africa Type 1 Diabetes Drugs Sales and Market Share by Application
5.4 Africa Type 1 Diabetes Drugs Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Type 1 Diabetes Drugs Sales Volume by Countries (2012-2017)
5.4.2 Africa Type 1 Diabetes Drugs Revenue by Countries (2012-2017)
5.4.3 South Africa Type 1 Diabetes Drugs Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Type 1 Diabetes Drugs Sales and Growth Rate (2012-2017)
5.4.5 Egypt Type 1 Diabetes Drugs Sales and Growth Rate (2012-2017)
5.4.6 Algeria Type 1 Diabetes Drugs Sales and Growth Rate (2012-2017)

6 EMEA Type 1 Diabetes Drugs Manufacturers/Players Profiles and Sales Data
6.1 Novo Nordisk(US)
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Type 1 Diabetes Drugs Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Novo Nordisk(US) Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Sanofi(DE)
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Type 1 Diabetes Drugs Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Sanofi(DE) Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Eli Lilly(UK)
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Type 1 Diabetes Drugs Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Eli Lilly(UK) Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 ASTRAZENECA(JP)
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Type 1 Diabetes Drugs Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 ASTRAZENECA(JP) Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Medtronic(IT)
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Type 1 Diabetes Drugs Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Medtronic(IT) Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Insulet(US)
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Type 1 Diabetes Drugs Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Insulet(US) Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 TANDEM(CH)
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Type 1 Diabetes Drugs Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 TANDEM(CH) Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 ATI(US)
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Type 1 Diabetes Drugs Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 ATI(US) Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Novartis(US)
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Type 1 Diabetes Drugs Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Novartis(US) Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 BOEHRINGER INGELHEIM(US)
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Type 1 Diabetes Drugs Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 BOEHRINGER INGELHEIM(US) Type 1 Diabetes Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Bristol-Myers Squibb(US)
6.12 Takada(US)
6.13 HUADONG MEDICINE(DE)
6.14 Kelun(US)
6.15 NCPC(US)
6.16 Wanbang(IT)
6.17 Hisun(DE)
6.18 Yiling(US)
6.19 Gan & Lee(US)
6.20 Dongbao(IT)
6.21 JUMCAN(SK)
6.22 Taloph(US)
6.23 TIANAN(IT)
6.24 Ginwa(ES)
6.25 Baiyun Mountain(JP)
6.26 KOSAPLUS(KR)
6.27 Burkert(DE)

7 Type 1 Diabetes Drugs Manufacturing Cost Analysis
7.1 Type 1 Diabetes Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Type 1 Diabetes Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Type 1 Diabetes Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Type 1 Diabetes Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Type 1 Diabetes Drugs Market Forecast (2017-2022)
11.1 EMEA Type 1 Diabetes Drugs Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Type 1 Diabetes Drugs Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Type 1 Diabetes Drugs Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Type 1 Diabetes Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Type 1 Diabetes Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Type 1 Diabetes Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Type 1 Diabetes Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Type 1 Diabetes Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Type 1 Diabetes Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Type 1 Diabetes Drugs Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Type 1 Diabetes Drugs
Figure EMEA Type 1 Diabetes Drugs Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Type 1 Diabetes Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Peroral Drugs Product Picture
Figure Injection Product Picture
Figure EMEA Type 1 Diabetes Drugs Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Type 1 Diabetes Drugs by Application in 2016
Figure Hospital Examples
Figure Clinic Examples
Figure EMEA Type 1 Diabetes Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Type 1 Diabetes Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Type 1 Diabetes Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Type 1 Diabetes Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Type 1 Diabetes Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Type 1 Diabetes Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Type 1 Diabetes Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Type 1 Diabetes Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Type 1 Diabetes Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Type 1 Diabetes Drugs Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Type 1 Diabetes Drugs Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Type 1 Diabetes Drugs Sales Share by Players (2012-2017)
Figure 2016 Type 1 Diabetes Drugs Sales Share by Players
Figure 2017 Type 1 Diabetes Drugs Sales Share by Players
Figure EMEA Type 1 Diabetes Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Type 1 Diabetes Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Type 1 Diabetes Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Type 1 Diabetes Drugs Revenue Share by Players
Table 2017 EMEA Type 1 Diabetes Drugs Revenue Share by Players
Table EMEA Type 1 Diabetes Drugs Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Type 1 Diabetes Drugs Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Type 1 Diabetes Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Type 1 Diabetes Drugs by Type (2012-2017)
Figure EMEA Type 1 Diabetes Drugs Sales Market Share by Type (2012-2017)
Table EMEA Type 1 Diabetes Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Type 1 Diabetes Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Type 1 Diabetes Drugs by Type in 2016
Table EMEA Type 1 Diabetes Drugs Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Type 1 Diabetes Drugs Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Type 1 Diabetes Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Type 1 Diabetes Drugs by Application (2012-2017)
Figure EMEA Type 1 Diabetes Drugs Sales Market Share by Application in 2016
Table EMEA Type 1 Diabetes Drugs Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Type 1 Diabetes Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Type 1 Diabetes Drugs by Region (2012-2017)
Figure EMEA Type 1 Diabetes Drugs Sales Market Share in 2016
Table EMEA Type 1 Diabetes Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Type 1 Diabetes Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Type 1 Diabetes Drugs by Region (2012-2017)
Figure EMEA Type 1 Diabetes Drugs Revenue Market Share Regions in 2016
Table EMEA Type 1 Diabetes Drugs Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Type 1 Diabetes Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Type 1 Diabetes Drugs Revenue and Growth Rate (2012-2017)
Table Europe Type 1 Diabetes Drugs Sales (K Units) by Type (2012-2017)
Table Europe Type 1 Diabetes Drugs Market Share by Type (2012-2017)
Figure Europe Type 1 Diabetes Drugs Market Share by Type in 2016
Table Europe Type 1 Diabetes Drugs Sales (K Units) by Application (2012-2017)
Table Europe Type 1 Diabetes Drugs Market Share by Application (2012-2017)
Figure Europe Type 1 Diabetes Drugs Market Share by Application in 2016
Table Europe Type 1 Diabetes Drugs Sales (K Units) by Countries (2012-2017)
Table Europe Type 1 Diabetes Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Type 1 Diabetes Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Type 1 Diabetes Drugs Sales Market Share by Countries in 2016
Table Europe Type 1 Diabetes Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Type 1 Diabetes Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Type 1 Diabetes Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Type 1 Diabetes Drugs Revenue Market Share by Countries in 2016
Figure Germany Type 1 Diabetes Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure France Type 1 Diabetes Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure UK Type 1 Diabetes Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Type 1 Diabetes Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Type 1 Diabetes Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Type 1 Diabetes Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Type 1 Diabetes Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Type 1 Diabetes Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Type 1 Diabetes Drugs Sales (K Units) by Type (2012-2017)
Table Middle East Type 1 Diabetes Drugs Market Share by Type (2012-2017)
Figure Middle East Type 1 Diabetes Drugs Market Share by Type (2012-2017)
Table Middle East Type 1 Diabetes Drugs Sales (K Units) by Applications (2012-2017)
Table Middle East Type 1 Diabetes Drugs Market Share by Applications (2012-2017)
Figure Middle East Type 1 Diabetes Drugs Sales Market Share by Application in 2016
Table Middle East Type 1 Diabetes Drugs Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Type 1 Diabetes Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Type 1 Diabetes Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Type 1 Diabetes Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Type 1 Diabetes Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Type 1 Diabetes Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Type 1 Diabetes Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Type 1 Diabetes Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Type 1 Diabetes Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Type 1 Diabetes Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Type 1 Diabetes Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Type 1 Diabetes Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Type 1 Diabetes Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Type 1 Diabetes Drugs Sales (K Units) by Type (2012-2017)
Table Africa Type 1 Diabetes Drugs Sales Market Share by Type (2012-2017)
Figure Africa Type 1 Diabetes Drugs Sales Market Share by Type (2012-2017)
Figure Africa Type 1 Diabetes Drugs Sales Market Share by Type in 2016
Table Africa Type 1 Diabetes Drugs Sales (K Units) by Application (2012-2017)
Table Africa Type 1 Diabetes Drugs Sales Market Share by Application (2012-2017)
Figure Africa Type 1 Diabetes Drugs Sales Market Share by Application (2012-2017)
Table Africa Type 1 Diabetes Drugs Sales Volume (K Units) by Countries (2012-2017)
Table Africa Type 1 Diabetes Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Type 1 Diabetes Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Type 1 Diabetes Drugs Sales Market Share by Countries in 2016
Table Africa Type 1 Diabetes Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Type 1 Diabetes Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Type 1 Diabetes Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Type 1 Diabetes Drugs Revenue Market Share by Countries in 2016
Figure South Africa Type 1 Diabetes Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Type 1 Diabetes Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Type 1 Diabetes Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Type 1 Diabetes Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Novo Nordisk(US) Type 1 Diabetes Drugs Basic Information List
Table Novo Nordisk(US) Type 1 Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novo Nordisk(US) Type 1 Diabetes Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Novo Nordisk(US) Type 1 Diabetes Drugs Sales Market Share in EMEA (2012-2017)
Figure Novo Nordisk(US) Type 1 Diabetes Drugs Revenue Market Share in EMEA (2012-2017)
Table Sanofi(DE) Type 1 Diabetes Drugs Basic Information List
Table Sanofi(DE) Type 1 Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi(DE) Type 1 Diabetes Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi(DE) Type 1 Diabetes Drugs Sales Market Share in EMEA (2012-2017)
Figure Sanofi(DE) Type 1 Diabetes Drugs Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly(UK) Type 1 Diabetes Drugs Basic Information List
Table Eli Lilly(UK) Type 1 Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly(UK) Type 1 Diabetes Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Eli Lilly(UK) Type 1 Diabetes Drugs Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly(UK) Type 1 Diabetes Drugs Revenue Market Share in EMEA (2012-2017)
Table ASTRAZENECA(JP) Type 1 Diabetes Drugs Basic Information List
Table ASTRAZENECA(JP) Type 1 Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure ASTRAZENECA(JP) Type 1 Diabetes Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure ASTRAZENECA(JP) Type 1 Diabetes Drugs Sales Market Share in EMEA (2012-2017)
Figure ASTRAZENECA(JP) Type 1 Diabetes Drugs Revenue Market Share in EMEA (2012-2017)
Table Medtronic(IT) Type 1 Diabetes Drugs Basic Information List
Table Medtronic(IT) Type 1 Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Medtronic(IT) Type 1 Diabetes Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Medtronic(IT) Type 1 Diabetes Drugs Sales Market Share in EMEA (2012-2017)
Figure Medtronic(IT) Type 1 Diabetes Drugs Revenue Market Share in EMEA (2012-2017)
Table Insulet(US) Type 1 Diabetes Drugs Basic Information List
Table Insulet(US) Type 1 Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Insulet(US) Type 1 Diabetes Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Insulet(US) Type 1 Diabetes Drugs Sales Market Share in EMEA (2012-2017)
Figure Insulet(US) Type 1 Diabetes Drugs Revenue Market Share in EMEA (2012-2017)
Table TANDEM(CH) Type 1 Diabetes Drugs Basic Information List
Table TANDEM(CH) Type 1 Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure TANDEM(CH) Type 1 Diabetes Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure TANDEM(CH) Type 1 Diabetes Drugs Sales Market Share in EMEA (2012-2017)
Figure TANDEM(CH) Type 1 Diabetes Drugs Revenue Market Share in EMEA (2012-2017)
Table ATI(US) Type 1 Diabetes Drugs Basic Information List
Table ATI(US) Type 1 Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure ATI(US) Type 1 Diabetes Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure ATI(US) Type 1 Diabetes Drugs Sales Market Share in EMEA (2012-2017)
Figure ATI(US) Type 1 Diabetes Drugs Revenue Market Share in EMEA (2012-2017)
Table Novartis(US) Type 1 Diabetes Drugs Basic Information List
Table Novartis(US) Type 1 Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis(US) Type 1 Diabetes Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Novartis(US) Type 1 Diabetes Drugs Sales Market Share in EMEA (2012-2017)
Figure Novartis(US) Type 1 Diabetes Drugs Revenue Market Share in EMEA (2012-2017)
Table BOEHRINGER INGELHEIM(US) Type 1 Diabetes Drugs Basic Information List
Table BOEHRINGER INGELHEIM(US) Type 1 Diabetes Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BOEHRINGER INGELHEIM(US) Type 1 Diabetes Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure BOEHRINGER INGELHEIM(US) Type 1 Diabetes Drugs Sales Market Share in EMEA (2012-2017)
Figure BOEHRINGER INGELHEIM(US) Type 1 Diabetes Drugs Revenue Market Share in EMEA (2012-2017)
Table Bristol-Myers Squibb(US) Type 1 Diabetes Drugs Basic Information List
Table Takada(US) Type 1 Diabetes Drugs Basic Information List
Table HUADONG MEDICINE(DE) Type 1 Diabetes Drugs Basic Information List
Table Kelun(US) Type 1 Diabetes Drugs Basic Information List
Table NCPC(US) Type 1 Diabetes Drugs Basic Information List
Table Wanbang(IT) Type 1 Diabetes Drugs Basic Information List
Table Hisun(DE) Type 1 Diabetes Drugs Basic Information List
Table Yiling(US) Type 1 Diabetes Drugs Basic Information List
Table Gan & Lee(US) Type 1 Diabetes Drugs Basic Information List
Table Dongbao(IT) Type 1 Diabetes Drugs Basic Information List
Table JUMCAN(SK) Type 1 Diabetes Drugs Basic Information List
Table Taloph(US) Type 1 Diabetes Drugs Basic Information List
Table TIANAN(IT) Type 1 Diabetes Drugs Basic Information List
Table Ginwa(ES) Type 1 Diabetes Drugs Basic Information List
Table Baiyun Mountain(JP) Type 1 Diabetes Drugs Basic Information List
Table KOSAPLUS(KR) Type 1 Diabetes Drugs Basic Information List
Table Burkert(DE) Type 1 Diabetes Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Type 1 Diabetes Drugs
Figure Manufacturing Process Analysis of Type 1 Diabetes Drugs
Figure Type 1 Diabetes Drugs Industrial Chain Analysis
Table Raw Materials Sources of Type 1 Diabetes Drugs Major Manufacturers in 2016
Table Major Buyers of Type 1 Diabetes Drugs
Table Distributors/Traders List
Figure EMEA Type 1 Diabetes Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Type 1 Diabetes Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Type 1 Diabetes Drugs Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Type 1 Diabetes Drugs Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Type 1 Diabetes Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Type 1 Diabetes Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Type 1 Diabetes Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Type 1 Diabetes Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Type 1 Diabetes Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Type 1 Diabetes Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Type 1 Diabetes Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Type 1 Diabetes Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Type 1 Diabetes Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Type 1 Diabetes Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Type 1 Diabetes Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Type 1 Diabetes Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Type 1 Diabetes Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Type 1 Diabetes Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Type 1 Diabetes Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Type 1 Diabetes Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Type 1 Diabetes Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Type 1 Diabetes Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Type 1 Diabetes Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *